IE
ETON icon

Israel Englander’s Eton Pharmaceutcials ETON Stock Holding History

Israel Englander’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,939
Closed -$369K – 6009
2026
Q1 		$369K Sell
14,939
-64,392
-81% -$1.13M ﹤0.01% 4919
2025
Q4 		$1.34M Buy
79,331
+63,469
+400% +$1.12M ﹤0.01% 4261
2025
Q3 		$345K Buy
+15,862
New +$263K ﹤0.01% 5281
2025
Q2 		– Sell
-355,929
Closed -$4.62M – 5980
2025
Q1 		$4.62M Buy
355,929
+217,042
+156% +$3.28M ﹤0.01% 2942
2024
Q4 		$1.85M Buy
+138,887
New +$1.41M ﹤0.01% 3709
2024
Q1 		– Sell
-20,393
Closed -$89.3K – 6280
2023
Q4 		$89.3K Sell
20,393
-59,927
-75% -$240K ﹤0.01% 5374
2023
Q3 		$335K Buy
+80,320
New +$310K ﹤0.01% 4872
2022
Q4 		– Sell
-41,258
Closed -$87K – 6683
2022
Q3 		$87K Buy
+41,258
New +$103K ﹤0.01% 6013
2022
Q1 		– Sell
-20,700
Closed -$89K – 7048
2021
Q4 		$89K Sell
20,700
-410
-2% -$1.96K ﹤0.01% 6301
2021
Q3 		$106K Sell
21,110
-113,818
-84% -$592K ﹤0.01% 6410
2021
Q2 		$831K Buy
+134,928
New +$1,000K ﹤0.01% 4840

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Israel Englander's ETON Position: Q2 2026 in Review

Israel Englander sold out of Eton Pharmaceutcials (ETON) in Q2 2026, closing a stake of 14,939 shares — an estimated $369K sold.

Israel Englander first reported a position in ETON in Q2 2021 and held it in 11 quarters. The position peaked at $4.62M in Q1 2025. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Israel Englander reported no remaining Eton Pharmaceutcials position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 14,939 Eton Pharmaceutcials shares in Q2 2026, an estimated $369K.
  • Israel Englander first reported a position in Eton Pharmaceutcials in Q2 2021 and held it in 11 quarters.
  • Israel Englander's Eton Pharmaceutcials position peaked at $4.62M in Q1 2025.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.